Principal Scientist, Pharmaceutical Technology & Development, AstraZeneca
Liz joined AstraZeneca in 2003 as an Associate Principal Scientist specialising in Polymer Science, focussed on polymeric excipients used across a wide range of formulation platforms. Since 2014, in her broader role as a Principal Scientist in Material Attributes and Product Performance, she has responsibility for the development of materials control strategies for oral and parenteral drug product development and commercialisation, including both APIs and excipients. Whilst establishing herself as a subject matter expert in the discipline of pharmaceutical material science, Liz has also acquired experience in drug delivery and drug product formulation, analytical and process development. She has published numerous research papers and presented at international conferences and she has served as a main board member of the International Pharmaceutical Excipients Council of Europe for the last 6 years.